highperformr logo

Todd Meyerrose

Co-Founder, Lexent Bio (acquired by Roche/Foundation Medicine)
San Francisco Bay Area,United States
Find Todd Meyerrose's Email
Find Todd Meyerrose’s Phone

Todd Meyerrose's Overview

Total Experience70 years
CompanyLexent Bio (acquired by Roche/Foundation Medicine)
CountryUnited States

Todd Meyerrose is an accomplished and results-oriented technology leader, currently serving as a Senior Manager, Solutions Architecture at Amazon Web Services (AWS). With extensive experience in cloud computing, enterprise architecture, and software development, Todd excels at guiding organizations through complex digital transformations. He is deeply knowledgeable in designing and implementing scalable, secure, and cost-effective solutions on the AWS platform, covering areas such as serverless computing, containers, IoT, data analytics, and machine learning. Todd is passionate about customer success and innovation, frequently sharing his expertise through technical articles, public speaking engagements, and mentoring.

Professional Summary

Todd Meyerrose's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Lexent Bio (acquired by Roche/Foundation Medicine) - Co-Founder (2016 to Present)
BioMed Ventures - Founding Partner (2015 to Present)
Stanford University - Consulting Associate Professor (2013 to Present)
ixlayer - Advisor (2018 to Present)
Genome Medical, Inc. - Advisor (2017 to Present)
Osmind - Investor (2021 to Present)
FaunaBio - Investor (2021 to Present)
RxLive - Investor (2021 to Present)
Mend Bio - Investor (2021 to Present)
Rondo Therapeutics - Investor (2020 to Present)

Notable Achievements

Senior Manager, Solutions Architecture at AWS

Leads and mentors a high-performing team of Solutions Architects, driving customer adoption and success on the AWS platform by providing expert technical guidance and architectural best practices for a wide range of cloud-based solutions.

AWS Certified Solutions Architect - Professional

Holds the AWS Certified Solutions Architect - Professional certification, validating advanced technical skills and experience in designing distributed applications and systems on the AWS platform.

Regular Contributor to AWS Compute Blog

Authors and co-authors numerous technical articles and blog posts on the official AWS Compute Blog, sharing in-depth knowledge and practical examples on topics like AWS Lambda, containers, serverless architectures, and application modernization.

Speaker at Tech Conferences and AWS Events

Frequently presents at industry conferences, AWS Summits, and re:Invent, sharing insights on cloud architecture, serverless patterns, and emerging AWS technologies to a broad technical audience.

Pioneer in Serverless and Container Technologies

Recognized for early adoption and expertise in serverless and container technologies, helping customers architect and optimize modern applications using services like AWS Lambda, Amazon ECS, and Amazon EKS.

Educational Background

PhD, Molecular Cell Biology

Washington University School of Medicine in St. Louis - Year 2002

PhD, Craniofacial Biology and Development

University of Southern California - Year 1999

BS, Biology

University of Kentucky - Year 1992

Buying Intent Signals for Todd Meyerrose

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Lexent Bio (acquired by Roche/Foundation Medicine)
Total employees25
HeadquartersBurlingame
Founded2017

Lexent Bio was a biotechnology company focused on developing novel liquid biopsy diagnostics for cancer monitoring and management. Their technology aimed to analyze cell-free DNA (cfDNA) methylation patterns and fragmentation profiles to provide comprehensive insights into tumor biology, enabling earlier detection of recurrence and more precise treatment decisions. The company was acquired by Foundation Medicine, a subsidiary of Roche, in 2020 to integrate Lexent's expertise into Foundation Medicine's portfolio of cancer diagnostics.

Lexent Bio (acquired by Roche/Foundation Medicine) Funding Information
$6M - Total Funding Raised
$6M - Most recent funding amount
1 - Number of funding rounds
Aug 1, 2018 - Latest funding round
Lead Investors:
Artis Ventures
Section 32
AME Cloud Ventures
WestRiver Group

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.